Cargando…
Immunotherapy With Human Gamma Delta T Cells—Synergistic Potential of Epigenetic Drugs?
Autores principales: | Bhat, Jaydeep, Kouakanou, Léonce, Peters, Christian, Yin, Zhinan, Kabelitz, Dieter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5859364/ https://www.ncbi.nlm.nih.gov/pubmed/29593742 http://dx.doi.org/10.3389/fimmu.2018.00512 |
Ejemplares similares
-
Vitamin C, From Supplement to Treatment: A Re-Emerging Adjunct for Cancer Immunotherapy?
por: Kouakanou, Léonce, et al.
Publicado: (2021) -
Vitamin C supports conversion of human γδ T cells into FOXP3-expressing regulatory cells by epigenetic regulation
por: Kouakanou, Léonce, et al.
Publicado: (2020) -
Cancer immunotherapy with γδ T cells: many paths ahead of us
por: Kabelitz, Dieter, et al.
Publicado: (2020) -
Correction to: Cancer immunotherapy with γδ T cells: many paths ahead of us
por: Kabelitz, Dieter, et al.
Publicado: (2020) -
Contemplating Dichotomous Nature of Gamma Delta T Cells for Immunotherapy
por: Bhat, Jaydeep, et al.
Publicado: (2022)